Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

GlaxoSmithKline
Pharmaceuticals
AstraZeneca
Johnson and Johnson
AbbVie
Roche
Pfizer
Sanofi
Bayer
Topics

Advertisement

Advertisement

GlaxoSmithKline

Share

Top Latest Popular

In the last 2 hours

Bharat Biotech announces equitable pricing for Malaria vaccine The Hindu Business Line 09:12

In the last 8 hours

Hibsago Hepatitis B Shot Kept Virus Controlled in Nearly 1 in 5 Off Treatment but Carries Boxed Warning Medical Daily 04:28

Yesterday

Gavi, UNICEF Cut GSK Mosquirix Vaccine Price By 40% RTT News 16:47 Thu, 22 Oct

Advertisement

Advertisement

CSL nomme Deborah Waterhouse au poste de directrice générale et administratrice déléguée PR Newswire (Press Release) 16:04 Thu, 22 Oct

FDA approves GSK’s Hibsago as first functional cure for hepatitis B Pharmaceutical Technology 09:11 Thu, 22 Oct

Rescue team secures new permanent base at former GSK site North-West Evening Mail 06:58 Thu, 22 Oct

GSK, Ionis win US approval for first-of-its-kind hepatitis B drug BioPharma Dive 06:55 Thu, 22 Oct

Wednesday

GSK’s Hibsago clears FDA bar as first Aso in chronic hepatitis B BioWorld 20:02 Wed, 21 Oct

Inside A Pharma Giant's $800 Million Expansion In King Of Prussia Patch 18:22 Wed, 21 Oct

GSK’s Hibsago Will Transform Hep B Treatment But Leaves Room For Improvement Scrip Pharma Intelligence 15:33 Wed, 21 Oct

GSK picks up hep B drug approval STAT 15:27 Wed, 21 Oct

CSL nombra a Deborah Waterhouse consejera delegada y directora administrativa PR Newswire (Press Release) 14:22 Wed, 21 Oct

Five years of U.S. real-world evidence reinforce the durable effectiveness and long-term persistence of ViiV Healthcare’s Cabenuva Business Wire (Press Release) 14:02 Wed, 21 Oct

GSK hepatitis B drug approval supports £2.2bn sales forecast, Jefferies says Proactive Investors (US) 13:38 Wed, 21 Oct

GSK wins FDA green light for chronic hep B treatment Hibsago pharmaphorum 11:44 Wed, 21 Oct

GSK Gets FDA Nod for Hepatitis Drug, Names New HIV Chief Bloomberg Law 11:03 Wed, 21 Oct

GSK secures US approval for hepatitis B drug Hibsago ShareCast 10:11 Wed, 21 Oct

Advertisement

CSL appoints Deborah Waterhouse as CEO & Managing Director PR Newswire (Press Release) 08:56 Wed, 21 Oct

US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment The Economic Times 05:30 Wed, 21 Oct

Ionis partner GSK announces Hibsago (bepirovirsen) approved in the U.S. for the treatment of chronic hepatitis B (Chb) Business Wire (Press Release) 02:20 Wed, 21 Oct

Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (Chb) Business Wire (Press Release) 00:59 Wed, 21 Oct

Tuesday

GSK’s Jemperli wins accelerated nod in rectal cancer BioWorld 21:39 Tue, 20 Oct

GSK invests another $800M in Pennsylvania site expansions Pharmaceutical Processing World 17:59 Tue, 20 Oct

GSK’s Jemperli Approved In Rectal Cancer, Thanks To Investigator Study And Novel Endpoint Scrip Pharma Intelligence 17:40 Tue, 20 Oct

GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth Zacks 16:29 Tue, 20 Oct

Jemperli label extended to include rectal cancer pharmaphorum 14:54 Tue, 20 Oct

Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery Medical Daily 13:33 Tue, 20 Oct

GSK's Jemperli Becomes First Approved Immunotherapy For MSI-H/dMMR Locally Advanced Renal Cancer RTT News 04:32 Tue, 20 Oct

Monday

Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer Business Wire (Press Release) 23:21 Mon, 19 Oct

Interview: Benjamín Naishtat & Esteban Bigliardi – Glaxo Ioncinema 15:01 Mon, 19 Oct

Jefferies backs GSK with 2,500p target after positive lung cancer drug results Proactive Investors (US) 11:58 Mon, 19 Oct

Data reveal is promising for GSK's lung cancer drug ris-rez pharmaphorum 10:06 Mon, 19 Oct

Digital platform cuts pharmaceutical quality-record approval times by up to 90% Pharmafile 09:09 Mon, 19 Oct

GSK's Ris‑Rez shows 61pc response rate in early lung cancer study ShareCast 09:09 Mon, 19 Oct

GSK layoffs spark blockades at Belgian sites The Bulletin 08:58 Mon, 19 Oct

GSK lung cancer drug shows 61% response rate in early global trial Proactive Investors (US) 07:23 Mon, 19 Oct

In the last month

Weekly Buzz: Rhhby, Teva Win FDA Nod; Mlab, GSK Cut Jobs; AZN, Vir Deals; Krys, ABBV Report Data RTT News 16:03 Fri, 16 Oct

Belgian Minister To Closely Monitor GSK Restructuring Plan RTT News 15:02 Fri, 16 Oct

Strikes at GSK’s Belgian sites over plans to cut 1200 jobs Chemistry World Magazine 09:06 Fri, 16 Oct

GSK (LSE:GSK) Could Be 14% Below Fair Value As R and D Spending Rises Simply Wall St 00:18 Fri, 16 Oct

Advertisement

Advertisement

GlaxoSmithKline News

NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis